Table 2.

The difference in BCVA in IE and UE between at baseline and at 1, 3, 6 and 12 months after treatment

Dose	Eye	Baseline	After treatment
			1 month	3 months	6 months	12 months
Low-dose	IE	1.58 ± 0.48	1.50 ± 0.55(0.669)	1.50 ± 0.41(0.658)	1.45 ± 0.44(0.324)	1.37 ± 0.40(0.042*)
	UE	1.45 ± 0.48	1.43 ± 0.55(0.999)	1.38 ± 0.45(0.810)	1.45 ± 0.47(1.000)	1.40 ± 0.51(0.945)
High-dose	IE	1.60 ± 0.65	1.50 ± 0.64(0.517)	1.43 ± 0.63(0.116)	1.48 ± 0.56(0.441)	1.45 ± 0.71(0.205)
	UE	1.52 ± 0.72	1.32 ± 0.88(0.094)	1.28 ± 0.83(0.023*)	1.23 ± 0.78(0.001*)	1.30 ± 0.91(0.062)

(*): Differences with p < 0.05 were considered statistically significant